🏆 Finalist — NIH Data Sharing Index (“S-Index”) Challenge

Benjamin N. Bell

Merck & Co., Inc., Rahway, NJ, USA (United States)

ORCID: 0000-0001-5356-0173

Immunology and MicrobiologyMedicine

Pilot corpus only

This score is computed over theSindex pilot corpus and does not cover the full scientific literature. Scores are relative to papers we have ingested — papers, authors, and institutions outside the pilot are not represented. Methodology.

Top 100%percentile

0Author DataRank

Indexed papers

0in pilot corpus

datarank_citation_only_1hop_v6· scope data_onlyMethodology

Papers

Driven by 9 papers. Top paper: “A Derivative of the D5 Monoclonal Antibody That Targets the gp41 N-Heptad Repeat of HIV-1 with Broad Tier-2-Neutralizing Activity”.

A Derivative of the D5 Monoclonal Antibody That Targets the gp41 N-Heptad Repeat of HIV-1 with Broad Tier-2-Neutralizing Activity

Journal of Virology(2021)10.1128/jvi.02350-20

N/A

0.584DataRank · unranked

14 citations

Maria V. Filsinger Interrante, Benjamin N. Bell, Clayton L. Brown, Theodora U. J. Bruun, Celia C. LaBranche +3 more

A derivative of the D5 monoclonal antibody that targets the gp41 N-heptad repeat of HIV-1 with broad tier-2 neutralizing activity

bioRxiv (Cold Spring Harbor Laboratory)(2020)10.1101/2020.10.23.352526

N/A

0DataRank · unranked

3 citations

Maria V. Filsinger Interrante, Benjamin N. Bell, Clayton L. Brown, Celia C. LaBranche, David C. Montefiori +2 more

Neutralizing antibodies targeting the SARS‐CoV‐2 receptor binding domain isolated from a naïve human antibody library

Protein Science(2021)10.1002/pro.4044

N/A

0DataRank · unranked

20 citations

Abigail E. Powell, Carlos Rodríguez, Jennifer R. Cochran, Peter S. Kim, Benjamin N. Bell

The high-affinity immunoglobulin receptor FcγRI potentiates HIV-1 neutralization via antibodies against the gp41 N-heptad repeat

Proceedings of the National Academy of Sciences(2021)10.1073/pnas.2018027118

N/A

0DataRank · unranked

26 citations

Maria V. Filsinger Interrante, Benjamin N. Bell, Adonis A. Rubio, Joseph G. Joyce, John W. Shiver +3 more

Neutralizing antibodies targeting the SARS-CoV-2 receptor binding domain isolated from a naïve human antibody library

bioRxiv (Cold Spring Harbor Laboratory)(2021)10.1101/2021.01.07.425806

N/A

0DataRank · unranked

2 citations

Abigail E. Powell, Carlos Rodríguez, Jennifer R. Cochran, Peter S. Kim, Benjamin N. Bell

Converting non-neutralizing SARS-CoV-2 antibodies into broad-spectrum inhibitors

Nature Chemical Biology(2022)10.1038/s41589-022-01140-1

N/A

0DataRank · unranked

27 citations

Eric Waltari, Izumi de los Rios Kobara, Benjamin N. Bell, Mary Kate Morris, Ya-Chen Cheng +4 more

Converting non-neutralizing SARS-CoV-2 antibodies targeting conserved epitopes into broad-spectrum inhibitors through receptor blockade

bioRxiv (Cold Spring Harbor Laboratory)(2022)10.1101/2022.01.24.477625

N/A

0DataRank · unranked

2 citations

Eric Waltari, Izumi de los Rios Kobara, Benjamin N. Bell, John E. Pak, Peter S. Kim +1 more

The high-affinity immunoglobulin receptor FcγRI potentiates HIV-1 neutralization via antibodies against the gp41 N-heptad repeat

bioRxiv (Cold Spring Harbor Laboratory)(2020)10.1101/2020.08.27.271064

N/A

0DataRank · unranked

3 citations

Maria V. Filsinger Interrante, Benjamin N. Bell, Adonis A. Rubio, Joseph G. Joyce, John W. Shiver +3 more

HIV-1 prehairpin intermediate inhibitors show efficacy independent of neutralization tier

Proceedings of the National Academy of Sciences(2023)10.1073/pnas.2215792120

N/A

0DataRank · unranked

3 citations

Theodora U. J. Bruun, Natalia Friedland, Peter S. Kim, Benjamin N. Bell